Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as against net profit of Rs 53.86 crore during the previous quarter ended June 2023. Sales rose 31.15% to Rs 387.52 crore in the quarter ended June 2024 as against Rs 295.47 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 387.52 | 295.47 | 31 |
OPM % | 9.82 | 22.76 | - |
PBDT | 46.31 | 75.19 | -38 |
PBT | 42.40 | 71.40 | -41 |
NP | -11.79 | 53.86 | PL |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account